Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. How common it is

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

Introduction There is an increase in the population of older adults, 65 years or older in South Carolina. Socio economic and environmental factors are linked to the diagnosis of Alzheimer’s Disease and related dementias (ADRD). The aim of this study was therefore, to characterize the incidence of ADRD by public health regions (PHR). Methods We estimated the incidence of ADRD for 2021using data from South Carolina Alzheimer’s Disease Registry (SCADR) and the Annual County Resident Population Estimates (ACRPE). The incidence of new cases per 100, 0000 population for each county, and PHR, and age-adjusted ADRD specific diagnosis were estimated. Poisson regression modeling was used to compare crude and ADRD specific incidence by PHRs. The incidence of ADRD by counties and PHRs was visualized using TIGERline files. Results A total of 18,955 registrants from the SCADR were included in this study. About 38% of the participants were between 75 and 84 years. Additionally, about 79% of the registrants had Alzheimer’s (AD) diagnosis. The crude incidence of ADRD was higher in the Pee Dee PHR (896 per 100,000). Among ADRD specific diagnosis, AD incidence was higher in the Pee Dee PHR (727 per 100,000), Vascular dementia (VaD) and Mixed dementia incidences were higher in the Upstate PHR. The crude incidence of ADRD differed significantly across all the PHRs (p < 0.05). Discussion Regional differences in the incidence of ADRD suggest possible disparities in healthcare access, socioeconomic conditions and geographical factors. Targeted interventions, and early screening among young populations should be prioritized.

What this study adds

Evidence grade: Low

The record lists 18,955 participants. The incidence of Alzheimer's disease and related dementias varied significantly across public health regions in South Carolina, with the highest crude incidence in the Pee Dee region. This regional variation highlights the need for targeted public health planning.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Amoatika, D. A., Miller, M. C., Adams, R. J., & Milano, N. J. (2025). Regional differences in the incidence of Alzheimer’s disease and related dementias in South Carolina. Frontiers in Neurology. https://doi.org/10.3389/fneur.2025.1584127

Vancouver

Amoatika DA, Miller MC, Adams RJ, Milano NJ. Regional differences in the incidence of Alzheimer’s disease and related dementias in South Carolina. Frontiers in Neurology. 2025. doi:10.3389/fneur.2025.1584127. PMID: 40979202.

BibTeX

@article{amoatika2025-40979202,
  author  = {Amoatika, Daniel A. and Miller, Maggi C. and Adams, Robert J. and Milano, Nicholas J.},
  title   = {{Regional differences in the incidence of Alzheimer’s disease and related dementias in South Carolina}},
  journal = {Frontiers in Neurology},
  year    = {2025},
  doi     = {10.3389/fneur.2025.1584127},
  pmid    = {40979202},
  url     = {https://doi.org/10.3389/fneur.2025.1584127}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

The incidence of Alzheimer's disease and related dementias varied significantly across public health regions in South Carolina, with the highest crude incidence in the Pee Dee region. This regional variation highlights the need for targeted public health planning.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 4 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 1 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 43 of 100.43 of 100 points earned57 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Frontiers in Neurology)
Journal's citation record 2 / 4 Frontiers in Neurology: journal h-index 162 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 4 / 4 18,955 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Nicholas J. Milano: h-index 7 (OpenAlex, whole career)
Institution's track record 1 / 3 Medical University of South Carolina: institution h-index 715 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40979202)
Free to read 2 / 2 Free to read
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.

Related studies in How common it is from nearby years

Also in How common it is

80 studies in the library are filed under How common it is with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The How common it is hub.

Similar studies

More on How common it is

See all studies in How common it is →